BIO News and Press, Bio-Rad Laboratories Inc. Class A From 01/19/23

Summary Bruker offers a range of advantages over peers: profitability, value, growth, and more. As such, the company is well-positioned to provide strong returns in the future. This article will address recent developments, highlight the advantages, and discuss the opportunity. ...

Eisai Aims to Advance Gastrointestinal Cancer Treatment with Research Across Multiple Tumor Types at ASCO GI 2023 TOKYO, Jan 18, 2023 - (JCN Newswire) - Eisai Co., Ltd. announced today the presentation of research across various types of gastrointestinal cancers during the 2023 Amer...

Eisai Files Marketing Authorization Application for Anti-Amyloid-Beta Protofibril Antibody Lecanemab for Early Alzheimer's Disease in Japan TOKYO, Jan 16, 2023 - (JCN Newswire) - Eisai Co., Ltd. and Biogen Inc. announced today that Eisai has submitted a marketing authorization appli...

Eisai Launches Renewed Sustainability Page TOKYO, Jan 13, 2023 - (JCN Newswire) - Eisai Co., Ltd. announced that it has renewed the Sustainability page of its corporate website and it is now accessible to the public. Sustainability Top Page www.eisai.com/sustainability/index.h...

Soligenix On Track to Deliver Important Front-Line Treatment to US Market in 2024 NEW YORK, NY, Jan 12, 2023 - (NewMediaWire) - PCG Digital -- Soligenix, Inc. (Nasdaq: SNGX), a late-stage biopharmaceutical company, is on track to deliver a safe and effective front-line treatment to ...

Novotech Acquires European CRO, Strengthens Global Operations SINGAPORE, Jan 12, 2023 - (ACN Newswire) - Novotech announced today the acquisition of EastHORN, a European CRO with clinical, medical and regulatory expertise in multiple strategically important locations across the cont...

Novotech Acquires US-based Drug Development Consulting Firm, CBR International SINGAPORE, Jan 12, 2023 - (ACN Newswire) - Novotech, the leading Asia Pacific centered biotech CRO today announced the acquisition of CBR International, a global product development, clinical oversight an...

Avance Clinical Celebrates GlobalReady Success as more than 40 Biotech Clients Enter Program San Francisco, Jan 11, 2023 - (ACN Newswire) - More than 40 biotech clients are now taking advantage of Avance Clinical's GlobalReady program which delivers streamlined clinical development ...

Eisai Submits Marketing Authorization Application for Lecanemab as Treatment for Early Alzheimer's Disease in Europe TOKYO, Jan 11, 2023 - (JCN Newswire) - Eisai Co., Ltd. and Biogen Inc. (Nasdaq: BIIB) announced today that Eisai has submitted a marketing authorization application (...

Eisai Submits Supplemental Biologics License Application to FDA for Traditional Approval of LEQEMBI (lecanemab-irmb) for the Treatment of Alzheimer's Disease TOKYO, Jan 9, 2023 - (JCN Newswire) - Eisai Co., Ltd. and Biogen Inc. announced Eisai has submitted a supplemental Biologics ...